LDX — Lumos Diagnostics Holdings Cashflow Statement
0.000.00%
- AU$20.21m
- AU$30.88m
- $10.54m
- 16
- 47
- 31
- 22
Annual cashflow statement for Lumos Diagnostics Holdings, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | R2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | Final | Final | Final |
Changes in Working Capital | — | 1.82 | 0.191 | 0.017 | 0.021 |
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -3.09 | -3.65 | -10.9 | -18 | -9.64 |
Capital Expenditures | -2.57 | -6.33 | -8.33 | -4.36 | -0.155 |
Purchase of Fixed Assets | |||||
Software Development Costs | |||||
Other Investing Cash Flow Items | -5.81 | — | — | — | 4.46 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -8.38 | -6.33 | -8.33 | -4.36 | 4.31 |
Financing Cash Flow Items | — | — | — | — | -0.134 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 14.3 | 7.88 | 63.3 | -10.9 | 0.652 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.89 | -2.1 | 44 | -36.9 | -4.96 |